North America Flowable Hemostats Market Forecast to 2028 - Regional Analysis - by Material, Product, Application, and End User

List of Tables

The North America flowable hemostats market is expected to grow from US$ 494.74 million in 2022 to US$ 742.49 million by 2028. It is estimated to grow at a CAGR of 7.0% from 2022 to 2028.

Research and Development (R&D) Activities Leading to Product Innovations Fuel North America Flowable Hemostats Market

Hemostat products are high in demand in the healthcare industry. Over the past several years, many hemostat products have been developed and utilized in several surgical procedures. Researchers are carrying out intensive research and development activities resulting in product innovations. For Instance, In December 2019, Ethicon's (Johnson & Johnson Medical Device Companies) new product, "SURGIFLO Hemostatic Matrix." SURGIFLOW flowable hemostatic product stops bleeding while performing surgery and is faster than FLOSEAL (manufactured by Baxter). Furthermore, In January 2018, Z-Medica, LLC, a leading developer and marketer of hemostatic devices introduced QuikClot Control+ which can help save lives and fill the unmet need of hospitals across the country. QuikClot Control+ is indicated for temporary control of internal organ space bleeding for patients displaying class III or class IV bleeding. It may even be used to control severe bleeding wounds such as surgical wounds and traumatic injuries. Thus, research and development activities leading to product innovations are predicted to deliver an impetus for the growth of the overall flowable hemostats market during the forecast period.

North America Flowable Hemostats Market Overview

North America Flowable Hemostats Market Revenue and Forecast to 2028 (US$ Million)

North America Flowable Hemostats Market Segmentation

The North America flowable hemostats market is segmented into material, product, application, end user, and country.

Based on material, the North America flowable hemostats market is bifurcated into bovine gelatin & porcine gelatin. The bovine gelatin segment held a larger share of the North America flowable hemostats market in 2022.

In terms of product, the North America flowable hemostats market is segmented into combination hemostats, passive hemostats, and active hemostats. The combination hemostats segment held the largest share of the North America flowable hemostats market in 2022.

Based on Application, the North America flowable hemostats market is categorized into general surgery, cardiac surgery, vascular surgery, orthopedic surgery, neuro and spine surgery, and others. The general surgery segment held the largest share of the North America flowable hemostats market in 2022.

Based on end user, the North America flowable hemostats market is segmented into hospitals and clinics, ambulatory surgery centers, and others. The hospitals and clinics segment held the largest share of the North America flowable hemostats market in 2022.

By country, the North America flowable hemostats market is categorized into the US, Canada, and Mexico. The US dominated the North America flowable hemostats market in 2022.

Baxter International Inc, Ethicon (Johnson & Johnson), Pfizer Inc, Teleflex Incorporated, 3-D Matrix Medical Technology, Biom'up, and Aegis Lifesciences are some of the leading companies operating in the North America North America flowable hemostats market.

Product Code: BMIRE00029826

1. Introduction

1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
- 1.3.1 North America Flowable Hemostats Market - By Material
- 1.3.2 North America Flowable Hemostats Market - By Product
- 1.3.3 North America Flowable Hemostats Market - By Application
- 1.3.4 North America Flowable Hemostats Market - By End User
- 1.3.5 North America Flowable Hemostats Market - By Country

2. Key Takeaways

3. Research Methodology

3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. North America Flowable Hemostats Market - Market Landscape

4.1 Overview
4.2 North America PEST Analysis
- 4.2.1 North America PEST Analysis
4.3 North America Experts Opinion

5. North America Flowable Hemostats Market - Key Market Dynamics

5.1 Market Drivers
- 5.1.1 Increasing Number of Injuries and Surgical Procedures
- 5.1.2 Rising Geriatric Population
5.2 Market Restraints
- 5.2.1 Shortage of Skilled Professionals and Poor Reimbursement Policies
5.3 Market Opportunities
- 5.3.1 Increasing Number of Hospitals and Surgical Centers
5.4 Future Trends
- 5.4.1 Research and Development (R&D) Activities Leading to Product Innovations
5.5 Impact Analysis

6. Flowable Hemostats Market - North America Analysis

6.1 North America Flowable Hemostats Market Revenue Forecast & Analysis

7. North America Flowable Hemostats Market Revenue Forecast & Analysis

7.1 North America Flowable Hemostats Market Analysis - By Material
7.2 North America Flowable Hemostats Market Share, by Material, 2021 and 2028 (%)
7.3 Bovine Gelatin
- 7.3.1 Overview
- 7.3.2 Bovine Gelatin: North America Flowable Hemostats Market- Revenue and Forecast to 2028 (US$ Million)
7.4 Porcine Gelatin
- 7.4.1 Overview
- 7.4.2 Porcine Gelatin: North America Flowable Hemostats Market- Revenue and Forecast to 2028 (US$ Million)

8. North America Flowable Hemostats Market- By Product

8.1 Overview
8.2 North America Flowable Hemostats Market Share, by Product, 2021 and 2028 (%)
8.3 Combination Hemostat
- 8.3.1 Overview
- 8.3.2 Combination Hemostat: North America Flowable Hemostats Market- Revenue and Forecast to 2028 (US$ Million)
8.4 Passive Hemostat
- 8.4.1 Overview
- 8.4.2 Passive Hemostat: North America Flowable Hemostats Market- Revenue and Forecast to 2028 (US$ Million)
8.5 Active Hemostat
- 8.5.1 Overview
- 8.5.2 Active Hemostat: North America Flowable Hemostats Market- Revenue and Forecast to 2028 (US$ Million)

9. North America Flowable Hemostats Market- By Application

9.1 Overview
9.2 North America Flowable Hemostats Market Share, by Application, 2021 and 2028 (%)
9.3 General Surgery
- 9.3.1 Overview
- 9.3.2 General Surgery: North America Flowable Hemostats Market- Revenue and Forecast to 2028 (US$ Million)
9.4 Cardiac Surgery
- 9.4.1 Overview
- 9.4.2 Cardiac Surgery: North America Flowable Hemostats Market- Revenue and Forecast to 2028 (US$ Million)
9.5 Vascular Surgery
- 9.5.1 Overview
- 9.5.2 Vascular Surgery: North America Flowable Hemostats Market- Revenue and Forecast to 2028 (US$ Million)
9.6 Orthopedic Surgery
- 9.6.1 Overview
- 9.6.2 Orthopedic Surgery: North America Flowable Hemostats Market- Revenue and Forecast to 2028 (US$ Million)
9.7 Neuro and Spine Surgery
- 9.7.1 Overview
- 9.7.2 Neuro and Spine Surgery: North America Flowable Hemostats Market- Revenue and Forecast to 2028 (US$ Million)
9.8 Others
- 9.8.1 Overview
- 9.8.2 Others: North America Flowable Hemostats Market- Revenue and Forecast to 2028 (US$ Million)

10. North America Flowable Hemostats Market Analysis - By End User

10.1 Overview
10.2 North America Flowable Hemostats Market Share, by End User, 2021 and 2028, (%)
10.3 Hospitals and Clinics
- 10.3.1 Overview
- 10.3.2 Hospitals and Clinics: North America Flowable Hemostats Market - Revenue and Forecast to 2028 (US$ Million)
10.4 Ambulatory Surgery Centers
- 10.4.1 Overview
- 10.4.2 Ambulatory Surgery Centers: North America Flowable Hemostats Market - Revenue and Forecast to 2028 (US$ Million)
10.5 Others
- 10.5.1 Overview
- 10.5.2 Others: North America Flowable Hemostats Market - Revenue and Forecast to 2028 (US$ Million)

11. North America Flowable Hemostats Market Revenue and Forecasts to 2028 - Country Analysis

11.1 North America: Flowable Hemostats Market
- 11.1.1 Overview
- 11.1.2 North America: Flowable Hemostats Market, by Country, 2022 & 2028 (%)
  - 11.1.2.1 US: Flowable Hemostats Market - Revenue and Forecast to 2028 (US$ Million)
    - 11.1.2.1.1 Overview
  - 11.1.2.2 US: Flowable Hemostats Market - Revenue and Forecast to 2028 (USD Million)
    - 11.1.2.2.1 US: Flowable Hemostats Market, by Material- Revenue and Forecast to 2028 (USD Million)
    - 11.1.2.2.2 US: Flowable Hemostats Market, by Product- Revenue and Forecast to 2028 (USD Million)
    - 11.1.2.2.3 US: Flowable Hemostats Market, by Application- Revenue and Forecast to 2028 (USD Million)
    - 11.1.2.2.4 US: Flowable Hemostats Market, End User - Revenue and Forecast to 2028 (USD Million)
  - 11.1.2.3 Canada: Flowable Hemostats Market - Revenue and Forecast to 2028 (US$ Million)
    - 11.1.2.3.1 Overview
    - 11.1.2.3.2 Canada: Flowable Hemostats Market - Revenue and Forecast to 2028 (USD Million)
    - 11.1.2.3.3 Canada: Flowable Hemostats Market, by Material- Revenue and Forecast to 2028 (USD Million)
    - 11.1.2.3.4 Canada: Flowable Hemostats Market, by Product- Revenue and Forecast to 2028 (USD Million)
    - 11.1.2.3.5 Canada: Flowable Hemostats Market, by Application- Revenue and Forecast to 2028 (USD Million)
    - 11.1.2.3.6 Canada: Flowable Hemostats Market, End User - Revenue and Forecast to 2028 (USD Million)
  - 11.1.2.4 Mexico: Flowable Hemostats Market - Revenue and Forecast to 2028 (US$ Million)
    - 11.1.2.4.1 Overview
    - 11.1.2.4.2 Mexico: Flowable Hemostats Market - Revenue and Forecast to 2028 (USD Million)
    - 11.1.2.4.3 Mexico: Flowable Hemostats Market, by Material- Revenue and Forecast to 2028 (USD Million)
    - 11.1.2.4.4 Mexico: Flowable Hemostats Market, by Product- Revenue and Forecast to 2028 (USD Million)
    - 11.1.2.4.5 Mexico: Flowable Hemostats Market, by Application- Revenue and Forecast to 2028 (USD Million)
    - 11.1.2.4.6 Mexico: Flowable Hemostats Market, End User - Revenue and Forecast to 2028 (USD Million)

12. North America Flowable Hemostats Market-Industry Landscape

12.1 Overview
12.2 Growth Strategies in the Flowable Hemostats Market (%)
12.3 Organic Developments
- 12.3.1 Overview
12.4 Inorganic Developments
- 12.4.1 Overview

13. Company Profiles

13.1 Baxter International Inc
- 13.1.1 Key Facts
- 13.1.2 Business Description
- 13.1.3 Products and Services
- 13.1.4 Financial Overview
- 13.1.5 SWOT Analysis
- 13.1.6 Key Developments
13.2 Ethicon (Johnson & Johnson)
- 13.2.1 Key Facts
- 13.2.2 Business Description
- 13.2.3 Products and Services
- 13.2.4 Financial Overview
- 13.2.5 SWOT Analysis
- 13.2.6 Key Developments
13.3 Pfizer Inc.
- 13.3.1 Key Facts
- 13.3.2 Business Description
- 13.3.3 Products and Services
- 13.3.4 Financial Overview
- 13.3.5 SWOT Analysis
- 13.3.6 Key Developments
13.4 Teleflex Incorporated
- 13.4.1 Key Facts
- 13.4.2 Business Description
- 13.4.3 Products and Services
- 13.4.4 Financial Overview
- 13.4.5 SWOT Analysis
- 13.4.6 Key Developments
13.5 3-D Matrix Medical Technology
- 13.5.1 Key Facts
- 13.5.2 Business Description
- 13.5.3 Products and Services
- 13.5.4 Financial Overview
- 13.5.5 SWOT Analysis
- 13.5.6 Key Developments
13.6 Biom'up
- 13.6.1 Key Facts
- 13.6.2 Business Description
- 13.6.3 Products and Services
- 13.6.4 Financial Overview
- 13.6.5 SWOT Analysis
- 13.6.6 Key Developments
13.7 Aegis Lifesciences
- 13.7.1 Key Facts
- 13.7.2 Business Description
- 13.7.3 Products and Services
- 13.7.4 Financial Overview
- 13.7.5 SWOT Analysis
- 13.7.6 Key Developments

14. Appendix

14.1 About The Insight Partners
14.2 North America Glossary of Terms